A POTENT HUMAN INTERLEUKIN-4 ANTAGONIST STIMULATES THE PROLIFERATION OF MURINE CELLS EXPRESSING THE HUMAN INTERLEUKIN-4 BINDING CHAIN

被引:3
|
作者
DAVIS, ID
TREUTLEIN, HR
FRIEDRICH, K
BURGESS, AW
机构
[1] ROYAL MELBOURNE HOSP, COOPERAT RES CTR CELLULAR GROWTH FACTORS, MELBOURNE, VIC 3050, AUSTRALIA
[2] UNIV WURZBURG, THEODOR BOVERI INST BIOWISSENSCH BIOZENTRUM, D-97074 WURZBURG, GERMANY
关键词
INTERLEUKIN-4; RECEPTOR SUBUNITS; SIGNALING; ANTAGONISTS; MOLECULAR DYNAMICS; HOMOLOGY MODELING;
D O I
10.3109/08977199509003215
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A single-amino-acid substitution mutant form of human interleukin-4 (hIL-4), Y124D.hIL-4, has been described previously as an antagonist of the effects of hIL-4 on various human cells. The murine T-cell leukemic cell line CT.h4S, which expresses the human IL-4 receptor, proliferates in response to both hIL-4 and murine IL-4. Although Y124D.hIL-4 antagonizes the proliferative effects of hIL-4 on human phytohaemagglutinin-stimulated peripheral blood mononuclear cells, Y124D.hIL-4 is a potent stimulator for CT.h4S cells. Molecular modelling studies were performed to investigate the stability of different conformations of residue 124 as well as the efficiency of different molecular mechanics force fields in homology modelling. We suggest that the aspartate substitution alters the C-terminal end of the D-helix in such way that the analogue still binds to the human IL-4 receptor alpha-chain and signals through the murine gamma(c)-chain. In contrast, the Y124D.hIL-4/IL-4 receptor complex cannot signal through the human gamma(c)-chain.
引用
收藏
页码:69 / 83
页数:15
相关论文
共 50 条
  • [31] Interleukin-4 and Interleukin-4 Receptor Alpha Gene Polymorphisms in Recurrent Aphthous Stomatitis
    Najafi, Shamsolmoulouk
    Mohammadzadeh, Mahsa
    Rajabi, Fateme
    Bidoki, Alireza Zare
    Yousefi, Hila
    Farhadi, Elham
    Rezaei, Nima
    IMMUNOLOGICAL INVESTIGATIONS, 2018, 47 (07) : 680 - 688
  • [32] Effects of interleukin-4 on proteoglycan accumulation in human gingival fibroblasts
    Hashimoto-Uoshima, M
    Noguchi, K
    Suzuki, M
    Murata, A
    Yanagishita, M
    Ishikawa, I
    JOURNAL OF PERIODONTAL RESEARCH, 2002, 37 (01) : 42 - 49
  • [33] Characterization of caprine interleukin-4
    Snekvik, KR
    Beyer, JC
    Bertoni, G
    Von Beust, BR
    Baszler, TV
    Palmer, GH
    McElwain, TF
    Cheevers, WP
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2001, 78 (3-4) : 219 - 229
  • [34] Role of interleukin-4 in atherosclerosis
    Lee, YW
    Hirani, AA
    ARCHIVES OF PHARMACAL RESEARCH, 2006, 29 (01) : 1 - 15
  • [35] Interleukin-4, interleukin-4 receptor, and interleukin-18 polymorphisms and rheumatoid arthritis: a meta-analysis
    Song, Gwan Gyu
    Bae, Sang-Cheol
    Kim, Jae-Hoon
    Lee, Young Ho
    IMMUNOLOGICAL INVESTIGATIONS, 2013, 42 (06) : 455 - 469
  • [36] Role of interleukin-4 in atherosclerosis
    Yong Woo Lee
    Anjali A. Hirani
    Archives of Pharmacal Research, 2006, 29 : 1 - 15
  • [37] Interleukin-4 as a therapeutic target
    Gaertner, Yvonne
    Bitar, Lynn
    Zipp, Frauke
    Vogelaar, Christina Francisca
    PHARMACOLOGY & THERAPEUTICS, 2023, 242
  • [38] INTERLEUKIN-4 - A REGULATORY PROTEIN
    JANSEN, JH
    FIBBE, WE
    WILLEMZE, R
    KLUINNELEMANS, JC
    BLUT, 1990, 60 (05): : 269 - 274
  • [39] Associations of interleukin-4 and interleukin-4 receptor loci with esophageal squamous cell carcinoma susceptibility
    Wang, Jusi
    Chen, Tingyu
    Tang, Weifeng
    Kang, Mingqiang
    Chen, Shuchen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 97
  • [40] Elevated proliferation and interleukin-4 release from CD4(+) cells after chemotherapy in human Schistosoma haematobium infection
    Grogan, JL
    Kremsner, PG
    Deelder, AM
    Yazdanbakhsh, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (06) : 1365 - 1370